Welcome to our dedicated page for Aterian SEC filings (Ticker: ATER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aterian, Inc. (Nasdaq: ATER) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware corporation with publicly traded common stock, Aterian submits periodic and current reports that offer detail on its financial condition, operations, governance, and material events affecting the business.
Investors can review Aterian’s current reports on Form 8-K, which in the supplied data include earnings announcements for quarters ended June 30 and September 30, 2025, amendments to its Credit and Security Agreement, and disclosures related to executive and director changes. Other 8-K filings describe the company’s entry into a material definitive agreement with its lenders and the furnishing of press releases that summarize financial results and guidance.
The company’s definitive proxy statement on Schedule DEF 14A outlines matters submitted to stockholders at the 2025 annual meeting, such as the election of directors, ratification of the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. This document also explains record dates, voting procedures, and other governance details.
Over time, Aterian’s filings set is expected to include annual reports on Form 10-K, quarterly reports on Form 10-Q, additional Forms 8-K, and related exhibits. On Stock Titan, AI-powered tools can help summarize lengthy filings, highlight key sections on liquidity, credit agreements, and governance decisions, and make it easier to understand how individual disclosures fit into Aterian’s broader financial and strategic picture. Users can also monitor new filings as they are posted to EDGAR, including any future documents related to the company’s announced review of strategic alternatives.
Aterian, Inc. filed an amended Form 8-K to update Item 5.07, reporting the company’s decision on how often it will hold future non-binding advisory votes on executive compensation (say-on-pay). This amendment follows the 2025 annual meeting results and fulfills Item 5.07(d) disclosure requirements. No other changes were made to the prior Form 8-K. An Inline XBRL cover page file is included as Exhibit 104.
Aterian, Inc. reported Q3 2025 results with net revenue of
The company disclosed substantial doubt about its ability to continue as a going concern, citing ongoing losses, tariff-driven cost pressures, and dependence on external capital. Aterian amended its MidCap credit facility on
A fixed cost reduction plan announced on
Aterian, Inc. furnished a current report to announce it issued a press release with financial results for the three and nine months ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits) and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The report was signed by Chief Executive Officer Arturo Rodriguez.
Aterian, Inc. announced a leadership change. Chief Technology Officer Roi Zahut notified the company of his resignation, effective November 3, 2025. He will assist with the transition of his responsibilities through the effective date.
The company states Mr. Zahut is leaving to accept another executive position outside the company and that his resignation was not due to any disagreement regarding operations, policies, or practices.
Aterian, Inc. announced Amendment No. 4 to its Credit and Security Agreement dated August 29, 2025, with Midcap Funding IV Trust as administrative agent. The amendment temporarily reduced the Minimum Credit Party Liquidity covenant to $5.0 million for the defined Minimum Liquidity Covenant Reduction Period.
The amendment provides that if the company delivers a Liquidity Certificate showing at least $6.8 million of liquidity, the reduction period will end and the covenant will reset to $6.8 million. The amendment also establishes an Availability Reserve of $2.8 million during the reduction period and $1.0 million thereafter. Non-material schedules and exhibits were omitted from the filing.
William Kurtz, a director of Aterian, Inc. (ATER), reported the acquisition of 78,034 restricted shares of the issuer's common stock on 08/13/2025. These shares were granted under the companys 2018 Equity Incentive Plan and are subject to vesting. Following the grant, Mr. Kurtz beneficially owns 115,528 shares. The Form 4 was signed on 08/15/2025 and was filed as an individual report by one reporting person. No purchase price is reported because the grant price is listed as $0, consistent with a restricted stock award rather than a cash purchase.
Harlam Bari A, a director of Aterian, Inc. (ATER), acquired 78,034 shares of restricted common stock on 08/13/2025 under the issuer's 2018 Equity Incentive Plan at no cash cost. The restricted shares are subject to vesting, and after the grant the reporting person beneficially owns 137,260 shares. The Form 4 reports this non‑derivative equity award and indicates the filing was made by one reporting person.
Susan Lattmann, a director of Aterian, Inc. (ATER), reported acquiring 78,034 shares of restricted common stock on 08/13/2025 under the company’s 2018 Equity Incentive Plan. The acquisition is recorded as an award of restricted stock subject to vesting. After the reported transaction, Ms. Lattmann beneficially owns 136,910 shares. The Form 4 was signed on 08/15/2025 and indicates the filing is by one reporting person. The filing does not disclose vesting schedule details or any cash consideration.
Aterian, Inc. reported a significant decline in sales and continued losses in the first half of 2025 as trade policy changes and softer consumer demand weighed on its business. Net revenue for the quarter ended June 30, 2025 was $19.46 million, down 30.5% from $27.98 million a year earlier, and six-month revenue fell to $34.82 million from $48.20 million. The company recorded a quarterly net loss of $4.86 million and a six-month net loss of $8.76 million, with net loss per share of $0.63 for the quarter and $1.16 year-to-date. Gross margin contracted to 54.3% for the quarter as tariffs raised cost of goods sold and the company implemented price increases that reduced unit volumes.
The balance sheet shows $10.50 million of unrestricted cash and total cash and restricted cash of $11.69 million at June 30, 2025, inventory of $18.50 million, and an accumulated deficit of $720.4 million. Aterian is in compliance with its MidCap credit covenants as of June 30, 2025 and expects compliance through at least September 30, 2026, but discloses substantial doubt about near-term liquidity without additional capital. The company recognized restructuring charges of approximately $1.8 million tied to a May 2025 cost reduction plan expected to yield annualized savings of $5–6 million.
Aterian, Inc. furnished a press release reporting its financial results for the three and six months ended June 30, 2025; that press release is attached as Exhibit 99.1 and is incorporated by reference into the Form 8-K. The Form 8-K notes that the information in Item 2.02, including Exhibit 99.1, is being furnished under the Exchange Act and expressly is not deemed to be filed for purposes of Section 18 and is not incorporated by reference into other filings except by specific reference. The filing also lists a Cover Page Interactive Data File as Exhibit 104. The 8-K provides notice that the company has publicly disclosed its quarterly results via the attached press release, but it does not include any financial line-item figures or performance metrics within the filing itself.
FAQ
What is the current stock price of Aterian (ATER)?
What is the market cap of Aterian (ATER)?
